Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Hox-A2 (HOXA2) is a sequence-specific DNA-binding transcription factor essential for embryonic development in vertebrates, particularly in determining cell positional identity along the anterior-posterior axis. HOXA2 regulates morphogenesis and differentiation, and is critical for correct placement and formation of the lower and middle face, middle ear, and hindbrain segments. Mutations in HOXA2 are known to cause developmental syndromes such as microtia, hearing impairment, and cleft palate[1][2][3][7][8]. There is no current evidence that HOXA2 directly serves as a drug target or biomarker in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Hox-A2 (HOXA2).